Precision Vaccinations

 / January 21st, 2022

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Jan 21 • 2:04 pm CST
The U.S. National Center for Health Statistics ( NCHS ) Mortality Surveillance data available on January 20, 2022, found 25.5% of the deaths that occurred during the week ending January 15, 2022 (week #2) were due... READ →
Jan 21 • 1:39 pm CST
China-based Clover Biopharmaceuticals, Ltd. announced on January 20, 2022, that final efficacy data from SPECTRA, a global clinical trial evaluating its protein-based COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum), has been published in the peer-reviewed journal, The... READ →
Jan 21 • 11:27 am CST
Research published in the peer-reviewed journal Nature Communications on January 10, 2022, is one of several recent studies unlocking how previous responses to viruses help shape our future responses to COVID-19. The disease known as COVID-19... READ →
Jan 21 • 5:53 am CST
A study published by researchers at Mayo Clinic Cancer Center on December 12, 2021, found that cancer patients who receive chemotherapy ― and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells,... READ →
Jan 20 • 5:00 pm CST
Geneva-based Medicines Patent Pool (MPP) announced today that it had signed agreements with twenty-seven generic manufacturing companies to produce Merck's oral COVID-19 antiviral molnupiravir and supply the pills to 105 low- and-middle-income countries (LMICs). The sublicence... READ →

For more articles, try our search.